Personal Story
I’ve had symptoms of IBS for over the last two years or so… just before I graduated. I didn’t think much of it at first and thought the symptoms would pass. As a student my diet wasn’t great but it wasn’t that bad either. Soon afterwards the stomach pains became a part of my everyday […]
Personal Story
Hi everyone was I pleased to find this page as I’m at my wits end iv even starting goin to church ( which is something iv never done before but I do believe in my angels) iv suffered badly with EDS and everything that goes with it and as a child with unkind cruel parents […]
Personal Story
Kayla’s Personal Story: ‘School, friendships, even simple things became overwhelming, and I often felt misunderstood and alone” Hi, I’m Kayla. I’m a young woman, and since I was 14, I’ve dealt with constant stomach pain. It runs in my family, but that didn’t make it any easier—especially when people didn’t take it seriously or thought […]
Now available on our YouTube Channel! Watch Now Watch IFFGD’s 2026 Virtual Advocacy & Education Event Whether you are living with a chronic GI condition or you know someone who is, you understand the true impact of these conditions on those affected and the need for greater research funding for treatments and cures. This […]
Testimony
On September 12, 2017, Ceciel Rooker presented the following research information to the US Food and Drug Administration (FDA) concerning the burdens and needs of gastroparesis patients: On behalf of the International Foundation for Functional Gastrointestinal Disorders (IFFGD), we appreciate the opportunity provided by the FDA to hear the patient perspective at the Patient-Focused Drug […]
Personal Story
Kiyah’s Personal Story: The challenge to find the right diagnosis I’ve been suffering since 2020 with severe abdominal pain. I’ve had 3 endoscopies &’ one colonscopy &’ 3 different gastroentorologist. After the first endoscopy I was told by my GI doctor that I have GERD( acid reflux) &’ was place on a PPI called omeperazole […]
Testimony
IFFGD Founder and President Nancy Norton presented the following testimony on behalf of IFFGD members at a June 27, 2000 Center for Drug Evaluation and Research, Gastrointestinal Drugs Advisory Committee meeting on NDA 21-107, LOTRONEX (alosetron): Thank you, Members of the Committee. I hope you are not going to be tired of hearing from me […]
Overview_of_Research_in_Neurogastroenterology_Supported_by_the_NIH.pdf